23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
Por um escritor misterioso
Descrição
CEO Anne Wojcicki wants to make drugs using insights from millions of customer DNA samples, and doesn’t think that should bother anyone.
23andMe Is Really a Biotech Firm, Analyst Says - Barron's
SPAC Review: Potential, 23andMe Acquisition of VGAC, Artificial Intelligence & Genetics
How Accurate Is At-Home Genetic Testing?
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
Ancestry DNA Branches Out Into Genetic Health Screening
23andMe jumps into telehealth, prescription drug delivery with $400M buyout of Lemonaid Health
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
FDA Clears 23AndMe's DTC Breast Cancer Gene Test -- But 'Buyer Beware
23andMe to Use DNA Tests to Make Cancer Drugs - Bloomberg
23andMe, Twitter, 11/18/2021 6:29:02 AM, 266541
de
por adulto (o preço varia de acordo com o tamanho do grupo)
